Hostname: page-component-76fb5796d-45l2p Total loading time: 0 Render date: 2024-04-28T15:27:40.742Z Has data issue: false hasContentIssue false
  • English
  • Français

Hydroxyurea: Inhibition of DNA-Synthesis and Selective Susceptibility of S-Phase Cells In Vivo*

Published online by Cambridge University Press:  01 August 2014

F. S. Philips ,
H. S. Schwartz  and
S. S. Sternberg
F. S. Philips
Affiliation:
Division of Experimental Chemotherapy, Sloan-Kettering Institute for Cancer Research, New York City, N. Y.
H. S. Schwartz
Affiliation:
Division of Experimental Chemotherapy, Sloan-Kettering Institute for Cancer Research, New York City, N. Y.
S. S. Sternberg
Affiliation:
Division of Experimental Chemotherapy, Sloan-Kettering Institute for Cancer Research, New York City, N. Y.

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The cytotoxic effects of hydroxyurea and of related hydroxamic acid derivatives in vivo are briefly described. They occur selectively in tissues with high rates of cell renewal and they are of brief duration. Tissue concentration of hydroxyurea diminish rapidly as the result of renal excretion and metabolism; there is a close temporal relation between the physiological disposition of the agents and the cytotoxic changes. Hydroxyurea induces an immediate inhibition of DNA synthesis in proliferating tisdsues such as thymus, small intestine, and regenerating liver. Autoradiographic studies of mouse duodenum using tritiated thymidine have shown that the lethal susceptibility to hydroxyurea is restricted to cells in the S-phase of the mitotic cycles. Cells in G1, G2, and M are not damaged by the agent.

Type
Research Article
Information
Acta geneticae medicae et gemellologiae: twin research , Volume 17 , Issue 1 , January 1968 , pp. 5 - 8
Copyright
Copyright © The International Society for Twin Studies 1967

Footnotes

*

The original work summarized briefly herein is being published in detail elsewhere. It has been supported in part by grants CA-03192 and CA-08748 from the National Cancer Institute, U. S. Public Health Service.

References

Adamson, R. H. (1965). Activity of congeners of hydroxyurea against advanced leukemia L 1210. Proc. Soc. Exp. Biol. Med., 119: 456.Google Scholar
Adamson, R. H. et al. (1964). Some aspects of the antitumor activity and pharmacology of hydroxyurea. Arch. Int. Pharmacodyn. 153: 87.Google Scholar
Borenfreund, E. et al. (1961). Chromosome aberrations induced by hyponitrite and hydroxylamine derivatives. J. Nat. Cancer Inst., 47: 396.Google Scholar
Fishbein, W. N., Carbone, P. P. (1963). Hydroxyurea: mechanism of action. Science, 142: 1069.Google Scholar
Frenkel, E. P. et al. (1964). Studies on a metabolic defect induced by hydroxyurea (NSC-32065). Cancer Chemother. Rep., 40: 19.Google Scholar
Gale, G. R. (1964). Effect of hydroxyurea on the incorporation of thymidine into Ehrlich ascites tumor cells. Biochem. Pharmacol., 13: 1377.CrossRefGoogle ScholarPubMed
Gale, G. R. et al. (1964). Effect of hydroxyurea on Pseudomonas aeruginosa . Cancer Res., 24: 1012.Google Scholar
Krakoff, I. H. et al. (1963). Preliminary trials of hydroxyurea in neoplastic diseases in man. Proc. Amer. Ass. Cancer Res., 4: 35.Google Scholar
Mohler, W. C. (1964). Cytotoxicity of hydroxyurea (NSC-32065) reversible by pyrimidine deoxyribosides in a mammalian cell line grown in vitro . Cancer Chemother. Rep., 34: 1.Google Scholar
Patt, H. M., Quastler, H. (1963). Radiation effects on cell renewal and related systems. Physich Rev., 43: 357.Google Scholar
Philips, F. S. et al. (1964). Cytotoxicity and disposition of hydroxyurea and other hydroxyamates in rats. Proc. Amer. Ass. Cancer Res., 5: 50.Google Scholar
Rosenkranz, H. S., Levy, J. A. (1965). Hydroxyurea: a specific inhibitor of deoxyribonucleic acid synthesis. Biochem. Biochys. Acta, 95: 181.Google Scholar
Rosenthai, F. et al. (1928). Uber die Beziehungen von Schwersten Blutgiften zu Abbauprodukten des Eiweisses. Klin. Wschr., 7: 972.CrossRefGoogle Scholar
Schwartz, H. S. et al. (1965). Hydroxyurea: inhibition of deoxyribonucleic acis synthesis in regenerating liver of rats. Cancer Res., 25: 1867.Google Scholar
Sinclair, W. K. (1965). Hydroxyurea: differential lethal effects on cultured mammalian cells. Science, 150: 1729.Google Scholar
Somers, C. E., Hsu, T. C. (1961). Chromosome damage induced by hydroxylamine in mammalian cells. Proc. Nat. Acad. Sci. U. S. A., 47: 396.Google Scholar
Stearns, B. et al. (1963). Hydroxyurea. A new type of potential antitumor agent. J. Med. Chem., 6: 201.CrossRefGoogle ScholarPubMed
Thurman, W. G. et al. (1963). A phase I study of hydroxyurea. Cancer Chemother. Rep., 29: 103.Google Scholar
Yarbro, J. W. et al. (1965). Hydroxyurea inhibition of DNA synthesis in ascites tumor. Proc. Nat. Acad. Sci. USA., 53: 1033.Google Scholar
Young, C. W., Hodas, S. (1964). Hydroxyurea: inhibitory effect on DNA metabolism. Science, 146: 1172.CrossRefGoogle ScholarPubMed